Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma.

Ofer Margalit,Shun Yu,Einat Shacham-Shmueli,Gal Strauss,Yu-Xiao Yang,Yaacov R Lawerence,Kim A Reiss,Talia Golan,Naama Halpern,Dan Aderka,Bruce Giantonio,Ronac Mamtani,Ben Boursi

Journal of cancer research and clinical oncology（2022）

引用 1|浏览4

暂无评分

摘要

Single-agent adjuvant chemotherapy with a fluoropyrimidine in locally advanced gastric adenocarcinoma following D2 gastrectomy can improve overall survival in elderly patients. Clinicians may consider using either capecitabine or 5-FU as a treatment option in the adjuvant setting for this age group.

查看译文

关键词

5-Fluorouracil,Adjuvant chemotherapy,Capecitabine,Elderly patients,Gastric cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要